Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Machine learning prediction of adverse drug events with dolutegravir-based antiretroviral therapy
TCTR20230904001Completed
- Sponsor
- Pakchongnana Hospital
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of dolutegravir in human immunodeficiency virus infection (HIV), sponsored by Pakchongnana Hospital. Started May 2023; status: completed.
02
Drugs
dolutegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on TCTR20230904001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230904001.